Mesoblast Limited (MESO)
NASDAQ: MESO · Real-Time Price · USD
11.98
+0.26 (2.22%)
Dec 3, 2024, 12:14 PM EST - Market open
Mesoblast Employees
Mesoblast had 73 employees as of June 30, 2024. The number of employees decreased by 10 or -12.05% compared to the previous year.
Employees
73
Change (1Y)
-10
Growth (1Y)
-12.05%
Revenue / Employee
$80,849
Profits / Employee
-$1,204,877
Market Cap
1.36B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Pediatrix Medical Group | 5,450 |
Establishment Labs Holdings | 908 |
CareDx | 643 |
Progyny | 566 |
BioLife Solutions | 414 |
Aurinia Pharmaceuticals | 300 |
Rocket Pharmaceuticals | 268 |
Ardelyx | 267 |
MESO News
- 17 hours ago - Revascor Improves Survival and Reduces Major Morbidity in High-Risk Ischemic Heart Failure Patients With Inflammation - GlobeNewsWire
- 4 weeks ago - Appendix 4C Quarterly Activity Report for Quarter Ended September 30, 2024 - GlobeNewsWire
- 2 months ago - Mesoblast: Undervalued Due To Remestemcel-L's Substantial Growth Potential - Seeking Alpha
- 2 months ago - Mesoblast Option to Issue Up to US$50 Million Convertible Notes for Product Launch - GlobeNewsWire
- 3 months ago - Mesoblast Limited (MESO) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Mesoblast Reports Financial Results and Operational Update for Fiscal Year Ended June 30, 2024 - GlobeNewsWire
- 3 months ago - Mesoblast Financial Results and Corporate Update Webcast - GlobeNewsWire
- 4 months ago - Appendix 4C Quarterly Activity Report for Quarter Ended June 30, 2024 - GlobeNewsWire